Koztafit 250 Tablet Substitute
Strassenburg Pharmaceuticals Ltd
₹98
(₹14.0 per unit)
Macleods Pharmaceuticals Ltd
₹108
(₹15.43 per unit)
Mankind Pharma Pvt Ltd
₹124.5
(₹17.79 per unit)
Glenmark Pharmaceuticals Ltd
₹131.5
(₹18.79 per unit)
Micro Labs Ltd
₹132
(₹18.86 per unit)
Intas Pharmaceuticals Ltd
₹139.5
(₹19.93 per unit)
Inex Medicaments Pvt Ltd
₹213.5
(₹21.35 per unit)
Klm Laboratories Pvt Ltd
₹149.5
(₹21.36 per unit)
Abbott India Ltd
₹281.5
(₹28.15 per unit)
Glowderma Lab Pvt Ltd
₹303.5
(₹30.35 per unit)
Hegde & Hegde Pharmaceutica Llp
₹220
(₹31.43 per unit)
Cipla Ltd
₹486.5
(₹32.43 per unit)
Sun Pharmaceutical Industries Ltd
₹529.5
(₹35.3 per unit)
Dr Reddy's Laboratories Ltd
₹250.5
(₹35.79 per unit)
GlaxoSmithKline Pharmaceuticals Ltd
₹424.5
(₹60.64 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Koztafit 250 Tablet to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - TERBINAFINE-250MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Koztafit 250 Tablet is used to treat fungal infections of the fingernails, toenails, and skin. The detailed uses of Koztafit 250 Tablet are as follows:
Koztafit 250 Tablet treats fungal infections from within the body by reaching areas that topical medicines may not effectively penetrate. With regular use as prescribed, it helps eliminate the infection, relieve symptoms, and promote healthy skin and nail regrowth.
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX
RX